Optim'Care

E-health for transplant patients 

Image
julie_vandenbergue_pierre_marquet.jpg
Julie Vandenbergue and Pierre Marquet

Co-founders

After an organ transplant, an important follow-up is performed to ensure the graft, and the patient her/himself, are doing well. These monitorings include several clinical examinations and the analysis of biological data on specific dates, traditionally carried out during hospital consultations.

Created in 2018 by Julie Vandenbergue, an engineer with solid experience in the medical field, and Professor Pierre Marquet, a recognized transplant researcher, Optim'Care is the first specialized digital monitoring software for transplant patients. The solution is to be used by transplant departments to provide personalized patient care thanks to remote monitoring of their patients between consultations. A collaboration and a R&D project is underway with INSERM to integrate innovative algorithms to the solution.

The product has been EC marked  since 2019 and the device is reimbursed by the French National Health Insurance (“Sécurité Sociale”). The solution’s customers are hospitals, which then gradually deploy it to its own patients.

Necker and La Pitié Salpêtrière hospitals in Paris, Limoges University Hospital, and Toulouse hospitals have already adopted Optim'Care. By the end of 2020, a total of 1,000 patients should benefit from the solution.

 

Newfund Investor: Agathe Descamps

LinkedIn

Crunchbase